Page 5 - Nasdaq Tech News Today

Forsta AP Fonden boosted its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 203.0% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 111,800 shares of the biotechnology company’s stock after purchasing an additional 74,900 shares during the quarter. Forsta AP Fonden’s […]

Forsta AP Fonden raised its position in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 203.0% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 111,800 shares of the biotechnology company’s stock after acquiring an additional 74,900 shares during the quarter. Forsta AP Fonden […]

“FIIs are reducing their exposure to India, they will sell only what they own but then a time will come when the share prices will catch up with fundamentals and in comparison to other runups in the small and midcap space, financials still make reasonable sense. We are increasing exposure in the entire BFSI space.”

Sumitomo Mitsui Trust Holdings Inc. increased its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 14.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,365,042 shares of the biotechnology company’s stock after purchasing an additional 171,963 shares during […]

Bio-Techne (NASDAQ:TECH – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Wednesday. A number of other analysts also recently weighed in on TECH. Stephens reiterated an “overweight” rating and issued a $100.00 price target on shares of Bio-Techne in a […]

Shares of Bio-Techne Co. (NASDAQ:TECH – Get Free Report) hit a new 52-week low during trading on Tuesday . The company traded as low as $68.00 and last traded at $68.44, with a volume of 25900 shares traded. The stock had previously closed at $68.43. Analyst Ratings Changes Several brokerages have recently issued reports on […]

BTC Capital Management Inc. reduced its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 3.7% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 6,191 shares of the biotechnology company’s stock after selling 235 shares during the quarter. BTC Capital Management […]

Bio-Techne Co. (NASDAQ:TECH – Get Free Report) has received an average rating of “Moderate Buy” from the nine research firms that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year price target among […]

Sandler Capital Management lowered its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 50.8% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 84,285 shares of the biotechnology company’s stock after selling 86,995 shares during the period. Sandler Capital Management’s holdings in Bio-Techne […]

Element Capital Management LLC bought a new position in Bio-Techne Co. (NASDAQ:TECH – Free Report) during the 1st quarter, Holdings Channel.com reports. The fund bought 20,552 shares of the biotechnology company’s stock, valued at approximately $1,525,000. Several other hedge funds have also recently modified their holdings of TECH. Private Advisor Group LLC lifted its holdings […]